Skip to main content
OpenTrials
Completed

NCT Number: NCT05239247

Effects of Eldoa Versus Meckenzie Exercise on Non-specific Low Back Pain Patients

To determine the effects of Eldoa and Mckenzie exercises in posture. To determine the effects of Eldoa and Mckenzie exercises in ROM.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–69 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Rawal General And Dental Hospital

Islamabad, Federal, 44000, Pakistan

About this study

To determine the effects of Eldoa and Mckenzie exercises in pain. To determine the effects of Eldoa and Mckenzie exercises in Quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gender (Female)
  • Age (40-69)
  • NPRS (Grade <3)
  • Chronic pain (more than or equal to 3 months)
  • Restricted ROM
  • Lumbar straightening

Exclusion criteria

  • Any other orthopedic or neurological condition of hip or lumbar spine.
  • sign and symptoms of lower motor neuron disease.
  • Current use of medication prescribed for pain.
  • Radiculopathy.
  • malignancy.
  • Fracture.
  • Lumbar trauma.
  • Disc pathology

Treatment and study plan

Mckenzie extension exercise

Other

Hot pack applied on lumbar region for (ten minute). Mckenzie extension exercise performed 02 sets of 05 repetitions with 45 second hold and 15 sec rest between each set once a day.

TENS is applied on lumbar region for (ten minutes).

Eldoa stretch technique

Other

Hot pack applied on lumbar region for (ten minute). Eldoa stretch performed 02 sets of 05 repetitions with 45 second hold and 15 second rest between each set once a day.

TENS is applied on lumbar region for (ten minutes).

Primary outcomes

  1. lumbar ROM by inclinometer.

    Time frame: 12 days

    Flexion 60 Extension 25 Left Lat Flex 25 Right Lat Flex 25

  2. Lumbar Posture by flexicurve ruler.

    Time frame: 12 days

    Excessive lordosis (EL) is over 75°, normal lordosis (NL) is 40°, hypo-lordosis (HL) is in the 20°

Secondary outcomes

  1. pain on Numeric pain rating scale.

    Time frame: 12 days

    Changes from baseline, Pain was measured through Numeric pain rating scale.It comprises of a continuous scale of 10cm line.0 to 1 represent no pain, 1 to 3 represent mild pain ,4 to 6 represent moderate pain, 7 to 10 represent severe pain.

  2. functional outcome by Oswestry low back pain disability questionnaire.

    Time frame: 12 days

    0% to 20%: minimal disability: The patient can cope with most living activities. Usually no treatment is indicated apart from advice on lifting sitting and exercise. 21%-40%: moderate disability: The patient experiences more pain and difficulty with sitting, lifting and standing. Travel and social life are more difficult and they may be disabled from work. Personal care, sexual activity and sleeping are not grossly affected and the patient can usually be managed by conservative means. 41%-60%: severe disability: Pain remains the main problem in this group but activities of daily living are affected. These patients require a detailed investigation. 61%-80%: crippled: Back pain impinges on all aspects of the patient's life. Positive intervention is required. 81%-100%:These patients are either bed-bound or exaggerating their symptoms

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Feb 14, 2022
Registry last updated
Apr 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.